Growth Metrics

Mannkind (MNKD) Net Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 89.97%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -13.44%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 33.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -29.82%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 32.17%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -49.91%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -49.91%
Dec 31, 2025 -75.40%
Sep 30, 2025 55.28%
Jun 30, 2025 32.11%
Mar 31, 2025 26.35%
Dec 31, 2024 -30.48%
Sep 30, 2024 -47.03%
Jun 30, 2024 19.74%
Mar 31, 2024 -31.04%
Dec 31, 2023 120.77%
Sep 30, 2023 33.61%
Jun 30, 2023 -76.53%
Mar 31, 2023 21.57%
Dec 31, 2022 291.27%
Sep 30, 2022 3.00%
Jun 30, 2022 -13.38%
Mar 31, 2022 -15.84%
Dec 31, 2021 6.07%
Sep 30, 2021 11.85%
Jun 30, 2021 -605.58%
Mar 31, 2021 119.40%
Dec 31, 2020 -20.04%
Sep 30, 2020 22.54%
Jun 30, 2020 94.00%
Mar 31, 2020 -29.04%
Dec 31, 2019 72.35%
Sep 30, 2019 37.68%
Jun 30, 2019 -37.57%
Mar 31, 2019 -5.24%
Dec 31, 2018 32.42%
Sep 30, 2018 40.37%
Jun 30, 2018 66.19%
Mar 31, 2018 -1,816.81%
Dec 31, 2017 36.57%
Sep 30, 2017 -29.61%
Jun 30, 2017 -41.65%
Mar 31, 2017 39.52%
Dec 31, 2016 18.12%
Sep 30, 2016 -34.48%
Jun 30, 2016 309.87%
Mar 31, 2016 2.44%
Dec 31, 2015 -24.22%
Sep 30, 2015 -35.46%
Jun 30, 2015 17.94%
Mar 31, 2015 -96.18%
Dec 31, 2014 -36.94%
Sep 30, 2014 308.47%
Jun 30, 2014 30.97%
Mar 31, 2014 -22.30%
Dec 31, 2013 10.28%
Sep 30, 2013 -2.10%